Skip to main content
Saniona logo

Saniona — Investor Relations & Filings

Ticker · SANION ISIN · SE0005794617 LEI · 549300XO4L9XNOCFCZ84 ST Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2022-09-30 Capital/Financing Update
Country SE Sweden
Listing ST SANION

About Saniona

http://saniona.com

Saniona is a clinical-stage biopharmaceutical company focused on the research and development of treatments for neurological disorders, with a primary emphasis on epilepsy. The company is a leader in the field of ion channel modulation, leveraging its expertise and a proprietary drug discovery engine to create new medicines. Saniona has developed an extensive library of over 20,000 proprietary molecules designed to target various ion channels. Its pipeline includes multiple potential new medicines advancing through clinical trials, with the goal of addressing unmet medical needs for patients with central nervous system diseases.

Recent filings

Filing Released Lang Actions
Saniona extends runway and amends loan agreement with Formue Nord
Capital/Financing Update Classification · 100% confidence The document is a press release announcing an amendment to an existing loan agreement between Saniona and Formue Nord. It details the repayment of a portion of the loan, the extension of the maturity date, and the impact on the company's cash runway. This falls under the category of financing activities and capital structure updates.
2022-09-30 English
Sanionas kassa beräknas räcka längre efter ändring av låneavtalet med Formue Nord
Capital/Financing Update Classification · 100% confidence The document is a press release from Saniona announcing a modification to an existing loan agreement with Formue Nord. It details the repayment of 15 MSEK, the extension of the loan maturity date, and the impact on the company's cash runway. This falls under the category of company financing and capital structure updates.
2022-09-30 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Saniona AB for the period January to June 2022. It contains comprehensive financial data, including income statements, earnings per share, and detailed management commentary on business operations, pipeline progress, and restructuring. It is not a mere announcement (RPA) as it provides the full financial results and analysis for the specified period. H1 2022
2022-08-25 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'INTERIM REPORT FOR SANIONA AB (PUBL) January – June 2022'. It contains comprehensive financial data, including income statements for the three and six months ended June 30, 2022, business highlights, management commentary, and operational updates. It meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial statements and analysis for a period shorter than a full fiscal year. H1 2022
2022-08-25 English
Kommuniké från extra bolagsstämma den 18 augusti 2022 i Saniona AB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release titled 'Kommuniké från extra bolagsstämma' (Communiqué from the Extraordinary General Meeting) for Saniona AB. It details the results of the voting at the meeting, specifically regarding a share option program and the issuance of warrants. Since it reports the official results of a shareholder meeting vote, it falls under the 'Declaration of Voting Results & Voting Rights Announcements' category.
2022-08-18 Swedish
Bulletin from the Saniona AB extraordinary general meeting on August 18, 2022
AGM Information Classification · 95% confidence The document is a press release detailing the resolutions adopted at an 'extraordinary general meeting' (EGM). It covers the approval of an employee option program and the issuance of warrants. While it mentions voting results, it is specifically focused on the outcome of a general meeting regarding corporate governance and equity incentive plans, which aligns with the AGM-R (Annual General Meeting/General Meeting) category for meeting materials and resolutions.
2022-08-18 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.